We have located links that may give you full text access.
Subcutaneous versus intravenous fentanyl for labor pain management: A multicenter randomized controlled trial.
American journal of obstetrics & gynecology MFM. 2024 Februrary 10
BACKGROUND: Labor pain is the most intense pain experienced in woman's life. Epidural anesthesia is recommended as the most effective method for pain relief, but it has several limitations. Fentanyl is a high analgesic potency with short-acting duration, but the large-scale trials assessing the effectiveness and safety in labor pain management are still limited.
OBJECTIVES: To compare the effectiveness and harm as well as maternal satisfaction of subcutaneous (S.C.) versus intravenous (I.V.) fentanyl for labor pain management.
STUDY DESIGN: We conducted a multicenter open label randomized controlled trial. A total of 226 women were randomized to receive I.V. or S.C. fentanyl for labor pain management. Pain scores were evaluated before and after fentanyl administration at 5, 30, 60 minutes and then every 60 minutes until delivery. The data was analyzed based on intention-to-treat (ITT) principle.
RESULTS: Both I.V. and S.C. fentanyl significantly decreased labor pain from baseline to delivery, overall mean change -1.39 (95% confidence interval [CI], -1.62 to -1.17), and -0.89 (95% CI -1.24 to -0.05), respectively. The reduction of pain score between the two groups was not different, overall mean difference -0.35 (95% CI -0.76 to 0.05). Maternal satisfaction was high for both I.V. and S.C. fentanyl, 89.4% and 93.8%, respectively. There was no difference of maternal satisfaction rate between the two groups, relative risk 0.95 (95%CI 0.88 to 1.03). No serious maternal and neonatal adverse effects were observed.
CONCLUSION: Both I.V. and S.C. fentanyl were safe and significantly reduced pain from baseline to delivery among low-risk pregnancies. Maternal satisfaction in childbirth experience was high regardless of the route of administration of fentanyl administration. No serious adverse effects of fentanyl were observed in both mothers and neonates.
OBJECTIVES: To compare the effectiveness and harm as well as maternal satisfaction of subcutaneous (S.C.) versus intravenous (I.V.) fentanyl for labor pain management.
STUDY DESIGN: We conducted a multicenter open label randomized controlled trial. A total of 226 women were randomized to receive I.V. or S.C. fentanyl for labor pain management. Pain scores were evaluated before and after fentanyl administration at 5, 30, 60 minutes and then every 60 minutes until delivery. The data was analyzed based on intention-to-treat (ITT) principle.
RESULTS: Both I.V. and S.C. fentanyl significantly decreased labor pain from baseline to delivery, overall mean change -1.39 (95% confidence interval [CI], -1.62 to -1.17), and -0.89 (95% CI -1.24 to -0.05), respectively. The reduction of pain score between the two groups was not different, overall mean difference -0.35 (95% CI -0.76 to 0.05). Maternal satisfaction was high for both I.V. and S.C. fentanyl, 89.4% and 93.8%, respectively. There was no difference of maternal satisfaction rate between the two groups, relative risk 0.95 (95%CI 0.88 to 1.03). No serious maternal and neonatal adverse effects were observed.
CONCLUSION: Both I.V. and S.C. fentanyl were safe and significantly reduced pain from baseline to delivery among low-risk pregnancies. Maternal satisfaction in childbirth experience was high regardless of the route of administration of fentanyl administration. No serious adverse effects of fentanyl were observed in both mothers and neonates.
Full text links
Related Resources
Trending Papers
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app